News & Insights

Emergent Bioservices News, Insights & Events

Stay informed with news, insightful thought leadership, featured articles and engaging content from Emergent Bioservices and check out what events we’ll be attending throughout the year.

07.06.2020

Emergent BioSolutions Signs Five-Year Agreement for Large-Scale Drug Substance Manufacturing for Johnson & Johnson’s Lead COVID-19 Vaccine Candidate

Emergent will provide contract development and manufacturing services beginning in 2021 to produce drug substance at large...

06.17.2020

Editorial: Good Manufacturing Practices: Challenges with Compliance

Dino Muzzin, Senior Vice President, Manufacturing Operations at Emergent, recently contributed to an article in BioPharm...

06.02.2020

Emergent Continues to Expand Role in Support of Development and Manufacturing of COVID-19 Vaccines

Emergent BioSolutions recently announced that it has been issued a task order under an existing contract with the Biomedical...

06.01.2020

Emergent BioSolutions Joins U.S. Government’s Warp Speed Program in Landmark Public-Private CDMO Partnership for COVID-19 Vaccine Development and Manufacturing

Emergent and HHS expand 2012 CIADM public-private partnership with task order valued at approximately $628 million for rapid...

04.27.2020

May 4th Webinar: Rapid Readiness for Pandemic Response

Watch our latest webinar on the topic of how drug developers can maximize capacity, capabilities and expertise for pandemic...

04.27.2020

Emergent BioSolutions Signs Agreement to be U.S. Manufacturing Partner for Johnson & Johnson’s Lead Vaccine Candidate for COVID-19

GAITHERSBURG, Md., April 23, 2020 (GLOBE NEWSWIRE)

Emergent BioSolutions Inc. (NYSE:EBS) today announced an agreement whereby...